Aura Biosciences, Inc. Shares Outstanding (Cover Page)
Aura Biosciences, Inc. (AURA) had Shares Outstanding (Cover Page) of 103.70 million shares as of 2026-08-06, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-06: Entity Common Stock, Shares Outstanding 103.70M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 103.39M shares.
- 2026-03-24: Entity Common Stock, Shares Outstanding 64.15M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 63.50M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 103.70M shares 10-Q · filed 2026-08-11 |
| 2026-05-08 | 103.39M shares 10-Q · filed 2026-05-11 |
| 2026-03-24 | 64.15M shares 10-K · filed 2026-03-30 |
| 2025-11-10 | 63.50M shares 10-Q · filed 2025-11-13 |
| 2025-08-08 | 62.12M shares 10-Q · filed 2025-08-13 |
| 2025-05-09 | 50.27M shares 10-Q · filed 2025-05-15 |
| 2025-03-19 | 50.23M shares 10-K · filed 2025-03-24 |
| 2024-11-07 | 49.95M shares 10-Q · filed 2024-11-12 |
| 2024-08-05 | 49.61M shares 10-Q · filed 2024-08-08 |
| 2024-05-03 | 49.54M shares 10-Q · filed 2024-05-09 |
| 2024-03-20 | 49.50M shares 10-K/A · filed 2024-06-14 |
| 2023-11-03 | 38.26M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 38.20M shares 10-Q · filed 2023-08-09 |
| 2023-05-08 | 37.80M shares 10-Q · filed 2023-05-11 |
| 2023-03-10 | 37.80M shares 10-K · filed 2023-03-15 |
| 2022-11-07 | 29.33M shares 10-Q · filed 2022-11-10 |
| 2022-08-08 | 29.27M shares 10-Q · filed 2022-08-11 |
| 2022-05-09 | 29.26M shares 10-Q · filed 2022-05-12 |
| 2022-03-21 | 29.22M shares 10-K · filed 2022-03-23 |
| 2021-11-19 | 29.21M shares 10-Q · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |